COMMUNIQUÉS West-GlobeNewswire

Monte Rosa Therapeutics Announces Pricing of $300 Million Underwritten Public Offering
09/01/2026
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc . (“Monte Rosa”) (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today [...]
Tecan reports return to sales growth and strong order entry in the second half of 2025
09/01/2026
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports return to sales growth and strong order entry in the second half of 2025 Group sales of CHF 882.5 million, down 1.6% [...]
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), le 9 janvier 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui que des membres de son équipe dirigeante rencontreront les [...]
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
09/01/2026
Saint Herblain (France), January 09, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that members of its management team will meet one-on-one with existing [...]
ReadyRx Sermorelin: Prescription Telehealth Access in Injectable and ODT Formats — 2026 Platform Analysis of Compounding Standards and Provider Structure
09/01/2026
Market Analysis: How Three-Entity Telehealth Platforms Handle Prescription Peptide Evaluation, Compounded Medication Dispensing, and Realistic Timeline Variability AUSTIN, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]
True Keto Fusion Keto+ ACV Gummies: What Consumers Should Know as BHB-ACV Category Expands Into 2026
09/01/2026
An Informational Analysis of True Keto Fusion Gummies, BHB Ketone Salts, Apple Cider Vinegar Gummy Supplements, and Consumer Evaluation Criteria for the Keto ACV Gummies Category in 2026 Chicago, IL, Jan. 08, 2026 ( [...]
"Best Skin Tag Remover" Consumer Search Analysis: Topical Solutions vs Freezing Kits vs Clinical Procedures – NutriDerma Guard Format Overview
09/01/2026
January 2026 Consumer Report: At-Home Skin Tag Removal Format Comparison, Natural Ingredient Profile Context, and Product Selection Considerations for Topical vs Professional Methods Largo, FL, Jan. 08, 2026 (GLOBE [...]
"Best Peptides for Hair Growth" Search Trends Surge as Telehealth Platforms Expand FDA-Approved Medication Access in 2026
09/01/2026
January 2026 Consumer Report Examines How PeterMD and Similar Platforms Facilitate Prescription Hair Loss Treatment Access Through Licensed Telehealth Evaluation Vero Beach, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) -- [...]
AquaFit Weight Loss Supplement Investigation: 2026 Thermogenic Research Examines Green Tea, Berberine, and Metabolic Support Ingredients
09/01/2026
Alpha Lipoic Acid, Chromium, Cayenne, and Korean Ginseng Capsule Analysis Amid January 2026 Natural Weight Loss Supplement Search Trends AURORA, COLORADO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is [...]
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH)
08/01/2026
– Once-weekly TransCon ® CNP and TransCon ® hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of [...]
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues
08/01/2026
-- Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years-- BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX [...]
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis
08/01/2026
Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespective of modulator- [...]
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026
08/01/2026
SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its [...]
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automated Insulin Delivery (AID) System
08/01/2026
twiist™ becomes the first AID system compatible with Senseonics Eversense® 365 one-year CGM GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company [...]
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
08/01/2026
IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, unaudited topline [...]
ClinNEXUS Launches New Corporate Rebranding to Kick Off Attendance During Week of J.P. Morgan Healthcare Conference
08/01/2026
-Updated logo and website better reflect patient-centric focus and accessibility as well as new inflection point for company- -ClinNEXUS management will be in attendance during “JPM Week” hosting investor meetings and [...]
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
08/01/2026
Company to Highlight New Data from Phase 2 REVERT IPF Clinical Trial of TTI-101 in Podium Presentation HOUSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage [...]
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
08/01/2026
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health [...]
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology
08/01/2026
PONTE VEDRA, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]

Pages